PAK3 promotes the metastasis of hepatocellular carcinoma by regulating EMT process
Open Access
- 1 January 2022
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 13 (1) , 153-161
Abstract
Purpose: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. The malignant biological behavior of HCC is closely related to epithelial-mesenchymal transition (EMT), and EMT plays an important role in the progression, migration and metastasis of HCC. P21-activated kinase 3 (PAK3) is a serine/threonine protein kinase, and PAK3 affects the EMT, proliferation, metastasis and invasion of HCC.Keywords
This publication has 17 references indexed in Scilit:
- EMT: Present and future in clinical oncologyMolecular Oncology, 2017
- Lethality of PAK3 and SGK2 shRNAs to Human Papillomavirus Positive Cervical Cancer Cells Is Independent of PAK3 and SGK2 KnockdownPLOS ONE, 2015
- Molecular mechanisms of epithelial–mesenchymal transitionNature Reviews Molecular Cell Biology, 2014
- PAK signaling in cancerCellular Logistics, 2012
- The p21-activated Kinase 3 Implicated in Mental Retardation Regulates Spine Morphogenesis through a Cdc42-dependent PathwayJournal of Biological Chemistry, 2007
- P21-Activated Protein Kinase Is Overexpressed in Hepatocellular Carcinoma and Enhances Cancer Metastasis Involving c-Jun NH2-Terminal Kinase Activation and Paxillin PhosphorylationCancer Research, 2007
- Sequential implication of the mental retardation proteins ARHGEF6 and PAK3 in spine morphogenesisJournal of Cell Science, 2006
- A decade?s studies on metastasis of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2003
- Epithelial–mesenchymal transitions in development and pathologiesCurrent Opinion in Cell Biology, 2003
- p21-Activated kinases: three more join the PakThe International Journal of Biochemistry & Cell Biology, 2002